This is not the first time that the monkeypox virus has spread beyond Africa, its continent of origin. But the current epidemic is unprecedented for a number of reasons.
Helen Ayles, London School of Hygiene & Tropical Medicine
We expected to find that screening everybody for TB would identify individuals not yet diagnosed, and treating them quickly would reduce the prevalence of TB in the community.
Understanding the depth of vaccine hesitancy, and the drivers behind the lack of take-up is critical to preventing further deaths, infections, and continuing harm to the economy.
Michelle J. Groome, National Institute for Communicable Diseases; Juliet Pulliam, South African Centre for Epidemiological Modelling & Analysis (SACEMA) , and Sheetal Silal, University of Cape Town
Repeated resurgences of SARS-CoV-2 transmission are expected in the years to come.
People want a simple answer. Is this action safe? But despite Anthony Fauci bouncing responsibility for COVID-19 risk assessment to individuals, your risk can’t be boiled down to one probability.
The COVID-19 pandemic presents us with a unique opportunity to rethink and reform public health care in Canada. That’s why premiers’ demands for more unconditional health-care dollars are so misguided.
Public health remains the Cinderella of services when it comes to health budgets. But the pandemic has shown why New Zealand urgently needs a better investment approach.
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
Principal Medical Scientist and Head of Laboratory for Antimalarial Resistance Monitoring and Malaria Operational Research, National Institute for Communicable Diseases
Professor and Programme Director, SA MRC Centre for Health Economics and Decision Science - PRICELESS SA (Priority Cost Effective Lessons in Systems Strengthening South Africa), University of the Witwatersrand